Want to see HK:0546 full AI Analyst Report?
0546 Stock Chart & Stats
HK$8.00
HK$0.09(1.78%)
At close: 4:00 PM EST
HK$8.00
HK$0.09(1.78%)
Day’s Range― - ―
52-Week RangeHK$4.41 - HK$10.14
Previous CloseN/A
Volume3.61M
Average Volume (3M)4.55M
Market Cap
HK$11.86B
Enterprise ValueHK$10.62B
Total Cash (Recent Filing)HK$19.50B
Total Debt (Recent Filing)HK$18.39B
Price to Earnings (P/E)4.2
Beta0.65
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.31%
Share Statistics
EPS (TTM)0.98
Shares Outstanding2,507,346,000
10 Day Avg. Volume5,636,047
30 Day Avg. Volume4,549,355
Financial Highlights & Ratios
PEG Ratio1.11
Price to Book (P/B)0.91
Price to Sales (P/S)0.64
P/FCF Ratio73.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.22Price Target Upside2.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.88
Revenue Forecast (FY)HK$28.86B
Bulls Say, Bears Say
Bulls Say
Essential Ingredient PortfolioFufeng supplies staple, low-elasticity ingredients (MSG, amino acids, starches) to food, beverage and animal-nutrition customers. That product mix supports steady, structural demand and makes revenues less cyclical over months, anchoring volume-based cash generation.
By-product MonetizationSelling feed co-products boosts per-ton economics and diversifies revenue streams across food and animal markets. This downstream capture improves gross margins and utilization resilience, cushioning earnings from raw-material price swings over a multi-month horizon.
Positive Operating Cash GenerationDespite cyclical inputs and investment needs, operations have generated positive and reasonably steady cash in recent years. That operating cash provides liquidity to fund working capital and routine capex, supporting near-term operational continuity and creditor confidence.
Bears Say
Margin CompressionMargins have retraced from prior-cycle highs, indicating weaker pricing power or higher input costs. Sustained compression reduces internal cash generation and returns on invested capital, making the business more sensitive to corn and energy cost volatility over coming months.
Rising LeverageHigher debt-to-equity undermines financial flexibility and raises interest-service risk if margins or volumes weaken. Elevated leverage constrains strategic optionality—capex, M&A, or aggressive price responses—and increases refinancing sensitivity over a 2–6 month horizon.
Volatile, Weak Free Cash FlowFree cash flow volatility and near-breakeven FCF in 2025 signal working-capital swings and higher reinvestment or funding needs. Weak FCF limits capacity to cut debt or invest for growth, elevating execution and liquidity risk if adverse conditions persist.
Fufeng Group Limited News
0546 FAQ
What was Fufeng Group Limited’s price range in the past 12 months?
Fufeng Group Limited lowest stock price was HK$4.41 and its highest was HK$10.14 in the past 12 months.
What is Fufeng Group Limited’s market cap?
Fufeng Group Limited’s market cap is HK$11.86B.
When is Fufeng Group Limited’s upcoming earnings report date?
Fufeng Group Limited’s upcoming earnings report date is Aug 27, 2026 which is in 56 days.
How were Fufeng Group Limited’s earnings last quarter?
Fufeng Group Limited released its earnings results on Mar 26, 2026. The company reported HK$0.294 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.294.
Is Fufeng Group Limited overvalued?
According to Wall Street analysts Fufeng Group Limited’s price is currently Undervalued.
Does Fufeng Group Limited pay dividends?
Fufeng Group Limited pays a Notavailable dividend of HK$0.122 which represents an annual dividend yield of 5.31%. See more information on Fufeng Group Limited dividends here
What is Fufeng Group Limited’s EPS estimate?
Fufeng Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fufeng Group Limited have?
Fufeng Group Limited has 2,507,346,000 shares outstanding.
What happened to Fufeng Group Limited’s price movement after its last earnings report?
Fufeng Group Limited reported an EPS of HK$0.294 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.123%.
Which hedge fund is a major shareholder of Fufeng Group Limited?
Currently, no hedge funds are holding shares in HK:0546
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fufeng Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
12.61%
Trailing 12-Months
Asset Growth
11.56%
Trailing 12-Months
Company Description
Fufeng Group Limited
Fufeng Group Limited, an investment holding company, specializes in the global production and distribution of fermentation-based food additives, biochemicals, and starch-derived products, operating across markets in the People's Republic of China and internationally. Its business is structured into several key segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and an encompassing 'Other' segment. The Food Additives division is responsible for manufacturing and selling items such as monosodium glutamate (MSG), starch sweeteners, glutamic acid, compound seasonings, and corn oil. The Animal Nutrition segment focuses on producing and selling refined corn products, threonine, and lysine. High-end amino acids are offered through its dedicated segment, while the Colloid segment provides specialty gums like xanthan and gellan gum. The 'Other' segment encompasses a diverse range of products, including fertilizers, synthetic ammonia, and pharmaceuticals. Beyond these core activities, Fufeng Group is also engaged in the manufacturing and sale of construction materials such as autoclaved aerated concrete blocks and bricks, alongside eubacteria material medicine and various preparations. The company actively invests in the research, development, promotion, and industrialization of innovative biological techniques and their resultant achievements. Furthermore, it deals in cosmetics, biological products, and health foods, while also offering logistics, equity investment, and biological technique information services. Fufeng Group Limited was founded in 1999 and is headquartered in Linyi, People's Republic of China.
0546 Stock 12 Month Forecast
Average Price Target
HK$8.22
▲(2.75% Upside)
Technical Analysis
Huabao International Holdings
―
Yip's Chemical Holdings
―
China Boton Group Co., Ltd.
―
SANVO Fine Chemicals Group Limited
―
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
―
Options Prices
Currently, No data available
---